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ObJectives. The purpose of this study was to use volumetric 
intravascular ultrasound analysis of Palmaz-Schatz stents to 
assess the in-stent restenotic process. 
Background. By reducing lesion elastic recoil and chronic 
arterial remodeling, stents improve the long-term results of 
coronary angioplasty. However, stents are prone to the develop- 
ment of neointimal hyperplasia. Angiographic studies of stent 
restenosis have suggested that these hyperplastic responses are 
the cause of in-stent restenosis; however, it is difficult to visualize 
the radiolucent Palmaz-Schatz stent by angiography. Intravascu- 
lar ultrasound provides detailed cross-sectional imaging of the 
coronary arteries, especially the intense metallic reflection of 
endovascular stents. 
Methods. Forty-four patients with 60 Palmaz-Schatz stents 
underwent intravascular ultrasound imaging at follow-up ([mean 
+ SD] 8.8 _+ 7.2 months after implantation). Thirty-four stents 
were placed in saphenous vein grafts and 26 in native coronary 
arteries; 30 were placed in restenotic lesions, lntravascular ultra- 
sound with automatic transducer pullback at 0.5 mm/s allowed 
measurement of stent, lumen and intimai hyperplasia cross- 
sectional areas at l-ram axial increments within the stents. Using 
Simpson's rule, stent, lumen and intimal hyperplasia volumes 
were calculated. Patterns of in-stent restenosis were then identi- 
fied. 
Results. Restenotic stents had smaller stent volumes (120 ± 41 
vs. 147 -+ 43 mm 3, p = 0.016) and lumen volumes (62 -+ 28 vs. 
118 -+ 42 mm 3, p < 0.0001) but larger intimal hyperplasia 
volumes (58 +- 36 vs. 29 +- 18 mm 3, p < 0.001) than nonrestenotic 
stents. A focal restenosis pattern was more common (20 [77%] of 
26) than a diffuse restenosis pattern (6 [23%] of 26). Stents with 
focal restenosis and stents with diffuse restenosis had equally 
small stent volumes (120 ± 44 vs. 120 -+ 31 mm 3, respectively, p 
= NS); however, stents with diffuse restenosis had larger intimal 
hyperplasia volumes (84 +- 30 vs. 50 ± 34 mm 3, p < 0.05). Focal 
restenosis was most commonly located at the central articulation 
(45%); the location of focal restenosis was related to the focal 
accumulation of neointimai tissue. 
Conclusions. Stent volume and magnitude and distribution of 
intimai hyperplasia re important in the development of in-stent 
restenosis. Stent volume was smaller and intimai hyperplasia 
volume greater in restenotic stents. Stent restenosis is more 
commonly focal in nature and located at the central articulation. 
(J Am Coil Cardiol 1995;26:720-4) 
Stents were developed to improve the short- and long-term 
results of coronary angioplasty, and studies have shown re- 
duced restenosis rates with Palmaz-Schatz tubular slotted 
stents compared with balloon angioplasty. These reduced 
restenosis rates are believed to be the result of both a 
reduction in the lesion elastic recoil and an inhibition of late 
arterial remodeling responses. 
However, stented vessels are prone to the development of 
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neointimal hyperplasia, which may also lead to restenosis. In 
fact, some animal models have shown that stent placement 
actually increases mooth muscle cell proliferation. Because 
in-stent restenosis continues to be an important clinical prob- 
lem, a better understanding of the mechanisms involved may 
prove useful in developing more effective stent deployment 
and management s rategies. 
Although selective coronary angiography has been the 
reference standard for guiding revascularization, it has inher- 
ent limitations: errors caused by viewing a three-dimensional, 
tortuous vascular structure in only two dimensions; the inabil- 
ity to quantify the disease processes with negative contrast 
imaging; and ditliculty in consistently visualizing the relatively 
radiolucent stainless-steel Palmaz-Schatz prosthesis. Alterna- 
tively, intravascular ultrasound allows detailed, cross-sectional 
imaging of the coronary arteries. The normal coronary arterial 
wall, the major components of the atherosclerotic plaque, the 
intense metallic reflection of endovascular stents and the 
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quantitative changes in vessel and lumen dimensions can be 
studied in vivo in a manner otherwise not possible. Recently, 
volumetric intravascular ultrasound analysis has been applied 
to the assessment of the mechanisms and results of transcath- 
eter therapies (1). The purpose of the present study was to use 
volumetric intravascular ultrasound analysis of Palmaz-Schatz 
stents to assess the in-stent restenotic process (2-4). 
Methods 
Patients. The study included 44 patients (38 men, 6 
women; mean [-+SD] age 51 +_ 11 years, range 46 to 83). All 44 
patients had follow-up coronary angiography and intravascular 
ultrasound imaging at the Washington Hospital Center a mean 
of 8.8 + 7.2 months after stent placement. These patients 
represent a consecutive series of stents studied at follow-up 
before April 1994 and met the following criteria: native 
coronary (not biliary) stents, adequate imagcs performed using 
motorized catheter pullback and imaging before a subsequent 
intervention. Stent location was a saphenous vein graft for 34 
stents and a native coronary artery in 26. Six stents were placed 
in the aorto-ostial ocation. Thirty stents were placed in 
restenotic lesions. Fourteen stents were 3.0 ram; 25 were 
3.5 ram; and 21 were 4.0 ram. 
Angiographic analysis. Quantitative coronary angiography 
was performed by an independent angiographic ore labora- 
tory using an automated edge detection system (ImageComm, 
Santa Clara, CA). Minimal lumen diameter and reference 
lumen diameter were recorded in two orthogonal projections. 
Values from the "worst" view were used to calculate the lesion 
diameter stenosis at the stent site. 
Intravascular ultrasound procedure. Follow-up intravas- 
cular ultrasound studies of Palmaz-Schatz tubular slotted 
stents were performed before any subsequent procedure (e.g., 
balloon angioplasty of in-stent restenosis). To perform volu- 
metric analysis of in-stent restenosis, only imaging systems 
incorporating motorized transducer pullback (typically at 
0.5 ram/s) through a stationary imaging sheath were used for 
this study. Motorized transducer pullback through a stationary 
imaging sheath allows the transducer to move at the same 
speed as the proximal end of the catheter. The first system 
(Cardiovascular Imaging Systems/InterTherapy) incorporated 
a single-element 25-MHz transducer coupled to an angled 
mirror mounted on the tip of a flexible shaft and rotated at 
1,800 rpm within a 3.9F (1.3 ram) short monorail polyethylene 
imaging sheath to form planar cross-sectional images in real 
time. The second system (Cardiovascular Imaging Systems Inc) 
incorporated a 30-MHz beveled transducer rotated at 
1,800 rpm within a 3.2F (1.07 ram) imaging sheath. All studies 
were recorded only during transducer pullback onto high 
quality s-VHS tape for off-line analysis. 
Intravascular ultrasound measurements. Validation of 
measurements of arterial, lumen and plaque cross-sectional 
areas and volumes has been reported previously (1). In brief, 
on playback of the recorded studies, a frame was selected every 
2 s of videotape (given a pullback speed of 0.5 ram/s, each 2 s 
of video playback corresponds to 1 mm of axial lesion length). 
Thus, 15 image slices were identified within each stent (the 
Palmaz-Schatz stent measures 15 mm in length); these image 
slices were numbered 1 (distal margin) through 15 (proximal 
margin). Using computerized planimetry, the stent and lumen 
cross-sectional reas of each image slice were traced manually, 
and the cross-sectional rea of intimal hyperplasia present 
within the stent on each image slice was calculated as stent 
cross-sectional rea minus lumen cross-sectional rea. Stent 
and lumen volumes (in mm 3) were calculated using Simpson's 
rule, and the intimal hyperplasia volume (also in mm 3) was 
calculated as stent volume minus lumen volume. In addition, 
the minimal stent cross-sectional rea and minimal lumen 
cross-sectional rea within the stent were identified. 
Each stent was then compared with the reference lumen 
cross-sectional rea, which was the average of the proximal and 
distal reference lumen cross-sectional reas. The reference 
lumen cross-sectional reas were the lumen areas at the most 
visually normal anatomic ross sections within 10 mm proximal 
and distal to the stent but before any major side branches. If a 
stent was ostial in location, then only the distal reference 
lumen was measured. The stent and lumen cross-sectional 
measurements at each image slice (as well as at the minimal 
lumen cross-sectional area within the stent) were used to 
calculate the following: 
(Reference lumen cross-sectional rea 
Lesion lumen cross-sectional rea × 100 
Area stenosis . . . . .  ; 
Reference lumen cross-sectional rea 
Stent cross-sectional rea × 100 
Relative stent expansion = Reference lumen cross-sectional rea" 
Definitions of restenosis. Stents were considered restenotic 
if the intravascular ultrasound area stenosis (minimal lumen 
cross-sectional rea vs. reference lumen cross-sectional rea) 
was ->75% or if the quantitative angiographic diameter steno- 
sis was ->50%. The length of the stent with an ultrasound area 
stenosis ->75% was then tabulated and used to identify two 
patterns of in-stent restenosis: 1) diffuse = restenotic stent with 
an ultrasound area stenosis ->75% involving >50% of the 
length of the stent; focal - restenotic stent with an ultrasound 
area stenosis ->75% involving <50% of the length of the stent. 
The focal pattern was further divided into 1) a marginal 
pattern of restenosis (maximal area stenosis within 2 mm of the 
distal or proximal stent margins as long as the stent margin was 
also involved); 2) a central articulation pattern of restenosis 
(maximal area stenosis within 2 mm of the central articulation 
as long as the central articulation was also involved); and 3) 
body restenosis (maximal area stenosis was >2 mm away from 
the margins and central articulation of the stent and no 
involvement of the margins or central articulation). 
Finally, to further analyze the focal patterns of in-stent 
restenosis, the 15 image slices/stent were grouped into five 
segments: 1) slices 1 to 3 = the distal margin; 2) slices 4 and 5 = 
the distal body; 3) slices 6 to 10 = the central articulation; 4) 
slices 11 and 12 - the proximal body; and 5) slices 13 to 15 = 
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Table 1. Comparison of Lesion Site Quantitative Coronapy Angiographic and Planar Intravascular 
Ultrasound Analysis in Nonrestenotic Versus Restenotic Stents 
No Rcstcnosis Restenosis 
(n : 34) (n = 26) 




Reference (mm) 3.38 + !1.51 
Minimal lumen diameter (ram) 2.53 + 0.52 
Diameter stenosis (%) 24.8 ÷ 1131 
Intravascular ultrasound 
Reference lumen CSA (ram-') 11.7 +: 4.2 
Minimal lumcn CSA (mm') 5.91) + 2.48 
Minimal stent CSA (mm-') 8.97 + 3.111 
lntimal hyperplasia CSA (mm-] 3.06 + 1.88 
Area stenosis (ci } 48.9 - 16.4 
Stent expansion (~h) 79.7 - 19.8 
3.14 _+ 0.43 0.076 
0.90 ± 0.57 < 0.0001 
73.1) + 17.0 < 0.0001 
9.74 : 2.36 < (I.05 
1.79 _+ 0.89 < 0.0(X)I 
7.30 _+ 3.29 < 0.05 
5.49 + 3.31 < 0.001 
80.8 ± 8.93 < 0.0001 
74.8 _+ 31.1 0.572 
CSA = cross-sectional rea. 
the proximal margin. The stent, lumen and intimal hyperplasia 
cross-sectional reas at these five segments were then com- 
pared. 
Statistics. Statistical analysis was performed using Stat- 
View 4.02. Continuous data are presented as mean value + SD 
and categoric values as frequencies. Comparisons between 
restenotic and nonrestenotic stents were performed using the 
student test. Comparison of stent segments was done using 
factorial analysis of variance with post hoc analysis using the 
Fisher protected least significant difference. A p value -< 0.05 
was considered statistically significant. 
Resu l ts  
Quantitative angiographic results. Table 1 compares the 
quantitative angiographic and intravascular ultrasound lesion 
site measurements in nonrestenotic and restenotic stents. 
Twenty-six stents had in-stent restenosis. Restenotic stents had 
smaller minimal stent cross-sectional reas (7.3 + 3.29 vs. 
8.97 ± 3.01 mm 2, p < 0.05) and more intimal hyperplasia 
(5.49 _+ 3.31 vs. 3.06 : 1.88 mm 2, p < 0.001). Relative stent 
expansion was similar in both groups but overall was only 
77.7% _+ 25.0% of the reference lumen cross-sectional rea. 
Volumetric iutravascular ultrasound results. Table 2 com- 
pares the stent, lumen and intimal hyperplasia volumes for 
restenotic and nonrestenotic stents. Restenotic stents had 
smaller stent volumes (120 _+ 41 vs. 147 ~+ 43 mm -~, p = 0.016), 
smaller lumen volumes (62 +_ 28 vs. 118 + 42 mm 3, p < 0.0001 )
and larger intimal hyperplastic volumes (58 + 36 vs. 29 _ 
18 ram", p < 0.001). Intimal hyperplasia volumes did not 
correlate with duration of stent implantation. 
Patterns of restenosis. Focal restenosis was the most com- 
mon pattern of in-stent restenosis (20 [77%] of 26); diffuse 
restenosis was seen in only six stents. As shown in Table 3, 
there was no difference in volume between stents with a diffuse 
pattern of in-stent restenosis and stents with a focal pattern of 
in-stent restenosis (120 _+ 31 vs. 120 _+ 44 mm 3, respectively, 
p NS). However, in a diffuse pattern of restenosis, the lumen 
volumes were smaller (36 + 15 vs. 70 _+ 26 mm 3, p < 0.005) 
and the intimal hyperplastic volumes larger (84 + 30 vs. 50 _+ 
34 mm 3, p < 0.05). Focal restenosis was localized to the central 
articulation in nine stents (45%), to the stent margins in six 
stents (30%) and to just the body of the stent in five stents 
(25%). The duration of implantation of stents with a diffuse 
pattern of restenosis tended to be shorter than nonrestenotic 
stents or stents with a focal pattern of in-stent restenosis; 
however, this difference did not reach statistical significance. 
Analysis of the five stent segments (distal margin, distal 
body, central articulation, proximal body and proximal margin) 
in all 60 stents is shown in Table 4. There was no significant 
difference in stent cross-sectional rea among these five seg- 
ments. Mean lumen cross-sectional area was significantly 
smaller at the central articulation (5.7 _+ 3.3 mm 2) than at both 
stent margins, whereas mean lumen cross-sectional rea was 
larger at the proximal margin (7.2 _+ 3.5 mm 2) than at all other 
stent segments. The differences in lumen dimensions are 
Table 2. Comparison of Lesion Site Volumetric lntravascular 
Ultrasound Analysis in Nonrestenotic Versus Restenotic Stents 
No Restenosis Restenosis 
In 34) (n - 26) p 
(mean + SD) (mean = SD) Value 
Stent volume (mm 3) 147 + 43 120 ± 41 0.()1~ 
Lumen volume (mm ;) lib, + 42 62 ± 28 < 0.0001 
lntimal hyperplasia w)lume (ram") 29 _+ 18 58 + 36 < 0./)01 
Table 3. Volumetric Intravascular Ultrasound Analysis of 
Restenotic Stents According to Patterns of Restenosis 
Diffuse Focal 
(n - 6) (n - 211) p 
(mean ± SD) (mean ± SD) Value 
Stent volume (mm 3) 120 ± 31 120 ± 44 0.999 
Lumen volume (mm 3) 36 + 15 70 + 26 < 0.005 
Intimal hyperplasia volume (mm 3) 84 ± 30 50 _+ 34 < 0.05 
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Table 4. Overall Intravascular Ultrasound Analysis According to 
Stent Segments 
Intimal 
Stent CSA Lumen CSA Hyperplasia 
(mm 2 ) (mm 2) CSA (ram 2) 
(mean 2 SD) (mean + SD) (mean 2 SD) 
Proximal margin 9.3 + 3.0 7.2 _+ 3.5* 2.1 + 2.0* 
Proximal body 9.0 _+ 3.0 6.3 _+ 3.1 2.7 _+ 2.3 
Central articulation 8.9 _+ 3.3 5.7 + 3.3t 3.2 _+ 2.7t 
Distal body 8.8 _+ 3.1 5.9 + 3.6 2.9 _+ 2.6 
Distal margin 9.2 _+ 3.3 6.4 _+ 3.9 2.9 _+ 0.2 
*p < 0.05, proximal margin versus proximal body, distal body and distal 
margin. #p < 0.001, central articulation versus proximal margin, and p < 0.05, 
central articulation versus distal margin. CSA cross-sectional rea. 
explained by variable amounts of neointimal hyperplasia. 
Intimal hyperplasia was significantly less at the proximal 
margin (2.1 _+ 2.0 mm 2) than at all other segments, whereas 
intimal hyperplasia was greatest at the central articulation 
(3.2 _+ 2.7 mm2). 
Discuss ion  
Our results show that stent volume and magnitude and 
distribution of intimal hyperplasia re important in the devel- 
opment of in-stent restenosis. Stent volume was smaller in 
restenotic than nonrestenotic stents regardless of the pattern 
and location of in-stent restenosis. Similarly, intimal hyperpla- 
sia volume was greater in restenotic than nonrestenotic stents; 
the patterns of in-stent restenosis were related to the axial 
distribution of neointimal tissue. 
Stent volume. Stent volume was smaller in restenotic le- 
sions regardless of the pattern of in-stent restenosis. A small 
stent volume can be the result of either 1) a long-term and 
progressive decrease in stent volume due to extrinsic ompres- 
sion (i.e., long-term stent recoil) or 2) a reduced stent volume 
during initial implantation due to either limited expansion or 
small intrinsic vessel size. Angiographically, there is minimal 
acute elastic recoil immediately after Palmaz-Schatz stent 
implantation and no recoil at 24 h (5,6). Similarly, neither 
quantitative angiographic nor intravascular ultrasound analysis 
has shown significant long-term recoil (7-9). 
Numerous tudies (5,10,11) have shown the importance of 
achieving a large lumen after catheter-based r vascularization. 
Most of the stents analyzed in the present study had been 
deployed only with angiographic guidance. Recent reports 
(12,13) comparing intravascular ultrasound and angiography 
during stent implantation procedures have shown that angiog- 
raphy often misses early stent underexpansion. Similarly, the 
average relative stent expansion i  the present study was 77%; 
after ultrasound-guided high pressure adjunct balloon infla- 
tion, it is possible to achieve a stent cross-sectional rea equal 
to that of the reference lumen (relative stent expansion of 
100%) (12,14). Preliminary studies (14,15) have shown that 
ultrasound-guided high pressure adjunct balloon inflation 
strategies may further educe restenosis rates. 
The smaller stent volume in restenotic lesions could also 
have been related to the fact that these were smaller vessels. 
Because restenosis has been linked to small vessel size 
(11,16,17) and because stents may have a greater impact in 
reducing restenosis in smaller than larger vessels, it may be 
more important to achieve alarger stent volume and a greater 
relative stent expansion in smaller vessels. 
Intimal hyperplasia. Overall, neointimal hyperplasia vol- 
ume was greater in restenotic stents than in nonrestenotic 
stents, and the distribution of neointimal tissue was linked to 
the pattern of restenosis. Neointimal hyperplasia sa common 
and nonspecific response to arterial injury. Previous studies 
(7,18) have shown that intimal hyperplasia covers the entire 
stent. Similarly, we found some degree of intimal hyperplasia 
in every stent segment, whether or not the stent was restenotic. 
However, the degree of intimal hyperplasia was highly variable, 
from almost none to completely obliterating the lumen. 
Neointimal hyperplasia salso one of the main mechanisms 
of restenosis after angioplasty. Animal studies (19,20) using 
the pig model have shown that intimal hyperplasia is exag- 
gerated by stent implantation. Similarly, clinical studies 
(7,11,21,22) with the Palmaz-Schatz, Wallstent and Wiktor 
stents have pointed to intimal hyperplasia s the cause for 
in-stent restenosis. Because stents do not recoil, late lumen loss 
is directly related to the amount of cellular proliferation. 
Patterns of restenosis. We were able to define two main 
patterns of restenosis: a diffuse pattern and a focal pattern, the 
latter being more common. In both types, stent volumes were 
similar and smaller in restenotic than in nonrestenotic stents. 
Thus, the diffuse restenosis pattern was the result of a larger 
intimal hyperplasia burden than that with the focal restenosis 
pattern. This aggressive neointimal growth in the diffuse 
restenosis pattern has been associated with a higher frequency 
of recurrent restenosis after angioplasty than that with the 
focal pattern of restenosis (18). 
The location of the focal in-stent restenosis was related to 
the focal accumulation of neointimal tissue. Although focal 
restenosis was seen in every stent segment, it was more 
frequent at the central articulation, which, overall, was the site 
of the smallest lumen and the largest amount of neointimal 
tissue. These findings agree with previous angiographic studies 
that have also pointed to the central articulation as the most 
frequent site for restenosis n Palmaz-Schatz stents. It has been 
postulated (23) that the central articulation stimulates smooth 
muscle cell proliferation, perhaps related to the manner in 
which the Palmaz-Schatz stent expands. Alternatively, the 
central articulation may allow tissue intrusion during deploy- 
ment; the arterial injury at the central articulation may be 
greater; and the central articulation may allow more long-term 
intrusion of neointimal hyperplasia. Therefore, if technically 
possible, it seems prudent o avoid placing the central articu- 
lation at the site of tightest stenosis. Furthermore, these data 
support the development of new stent designs that would 
eliminate the central articulation as it is currently configured. 
Study limitations. The retrospective nature of the present 
study limited it to patients with angiographic and intravascular 
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ultrasound follow-up data. Thus, our patients may not repre- 
sent the general population of patients treated with stents, 
and there might be an overrepresentation of patients with 
restenotic stents. Nevertheless, comparisons between rest- 
enotic and nonrestenotic stents are valid to assess the rest- 
enotic process. Additionally, it would have been useful to have 
intravascular ultrasound studies before and after stent implan- 
tation to analyze and assess tent and reference vessel changes 
thoroughly during implantation and follow-up. 
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